BCCM
TECH icon

Blue Clay Capital Management’s Bio-Techne TECH Stock Holding History

Blue Clay Capital Management’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-40,856
Closed -$944K – 77
2014
Q4 		$944K Buy
+40,856
New +$935K 0.69% 38

Other funds holding TECH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
CWAM
Columbia Wanger Asset Management Chicago, Illinois $6.69B AUM 31.14% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
MPI
Mairs & Power Inc St Paul, Minnesota $10.9B AUM 27.5% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Blue Clay Capital Management's TECH Position: Q1 2015 in Review

Blue Clay Capital Management sold out of Bio-Techne (TECH) in Q1 2015, closing a stake of 40,856 shares — an estimated $944K sold.

Blue Clay Capital Management first reported a position in TECH in Q4 2014 and held it in 1 quarter. The position peaked at $944K in Q4 2014. 252 funds tracked by Wall St. Rank hold TECH as of Q1 2015.

  • Blue Clay Capital Management reported no remaining Bio-Techne position as of Q1 2015 after selling out during the quarter.
  • Blue Clay Capital Management sold 40,856 Bio-Techne shares in Q1 2015, an estimated $944K.
  • Blue Clay Capital Management first reported a position in Bio-Techne in Q4 2014 and held it in 1 quarter.
  • Blue Clay Capital Management's Bio-Techne position peaked at $944K in Q4 2014.
  • 252 funds tracked by Wall St. Rank held Bio-Techne as of Q1 2015.

Based on Blue Clay Capital Management's 13F filing for Q1 2015, filed 15 May 2015.